119 related articles for article (PubMed ID: 2775468)
21. The inhibitory effect of trifluoromethylphenylpiperazine on [3H]acetylcholine release in guinea pig hippocampal synaptosomes is mediated by a 5-hydroxytryptamine1 receptor distinct from 1A, 1B, and 1C subtypes.
Harel-Dupas C; Cloëz I; Fillion G
J Neurochem; 1991 Jan; 56(1):221-7. PubMed ID: 1824781
[TBL] [Abstract][Full Text] [Related]
22. Functional subsensitivity of 5-HT2A and 5-HT2C receptors mediating hyperthermia following acute and chronic treatment with 5-HT2A/2C receptor antagonists.
Mazzola-Pomietto P; Aulakh CS; Tolliver T; Murphy DL
Psychopharmacology (Berl); 1997 Mar; 130(2):144-51. PubMed ID: 9106912
[TBL] [Abstract][Full Text] [Related]
23. MK-212 increases rat plasma ACTH concentration by activation of the 5-HT1C receptor subtype.
King BH; Brazell C; Dourish CT; Middlemiss DN
Neurosci Lett; 1989 Oct; 105(1-2):174-6. PubMed ID: 2562060
[TBL] [Abstract][Full Text] [Related]
24. Involvement of 5-HT1C-receptors in drug-induced penile erections in rats.
Berendsen HH; Jenck F; Broekkamp CL
Psychopharmacology (Berl); 1990; 101(1):57-61. PubMed ID: 2343074
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the discriminative stimulus properties induced by 5-HT1 and 5-HT2 agonists in rats.
Arnt J
Pharmacol Toxicol; 1989 Feb; 64(2):165-72. PubMed ID: 2526950
[TBL] [Abstract][Full Text] [Related]
26. Serotonin agonists increase transferrin levels via activation of 5-HT1C receptors in choroid plexus epithelium.
Esterle TM; Sanders-Bush E
J Neurosci; 1992 Dec; 12(12):4775-82. PubMed ID: 1334504
[TBL] [Abstract][Full Text] [Related]
27. Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists.
Kennett GA; Whitton P; Shah K; Curzon G
Eur J Pharmacol; 1989 May; 164(3):445-54. PubMed ID: 2767117
[TBL] [Abstract][Full Text] [Related]
28. M-chlorophenylpiperazine increases blood pressure and heart rate in pithed and conscious rats.
Bagdy G; Szemeredi K; Zukowska-Grojec Z; Hill J; Murphy DL
Life Sci; 1987 Aug; 41(6):775-82. PubMed ID: 3112482
[TBL] [Abstract][Full Text] [Related]
29. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
Callahan PM; Cunningham KA
Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
[TBL] [Abstract][Full Text] [Related]
30. The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in rats.
Fuller RW; Snoddy HD
Endocrinology; 1979 Oct; 105(4):923-8. PubMed ID: 477605
[TBL] [Abstract][Full Text] [Related]
31. Effects of serotonin agonists on operant behavior in the squirrel monkey: quipazine, MK-212, trifluoromethylphenylpiperazine, and chlorophenylpiperazine.
McKearney JW
Pharmacol Biochem Behav; 1990 Jan; 35(1):181-5. PubMed ID: 2315357
[TBL] [Abstract][Full Text] [Related]
32. Nature of 5-HT1-like receptors mediating depressor responses in vagosympathectomized rats; close resemblance to the cloned 5-ht7 receptor.
De Vries P; Villalón CM; Heiligers JP; Saxena PR
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):90-9. PubMed ID: 9228195
[TBL] [Abstract][Full Text] [Related]
33. Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice.
Gleason SD; Shannon HE
Eur J Pharmacol; 1998 Jan; 341(2-3):135-8. PubMed ID: 9543230
[TBL] [Abstract][Full Text] [Related]
34. 5-HT1A and 5-HT1B agonists play a differential role on the respiratory frequency in rats.
Edwards E; Whitaker-Azmitia PM; Harkins K
Neuropsychopharmacology; 1990 Apr; 3(2):129-36. PubMed ID: 2138459
[TBL] [Abstract][Full Text] [Related]
35. Stimulus generalization of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) to propranolol, pindolol, and mesulergine.
Glennon RA; Pierson ME; McKenney JD
Pharmacol Biochem Behav; 1988 Jan; 29(1):197-9. PubMed ID: 2895480
[TBL] [Abstract][Full Text] [Related]
36. Repeated treatment with d-fenfluramine or metergoline alters cortex binding of 3H-serotonin and serotenergic sensitivity in rats.
Samanin R; Mennini T; Ferraris A; Bendotti C; Borsini F
Eur J Pharmacol; 1980 Jan; 61(2):203-6. PubMed ID: 7353591
[TBL] [Abstract][Full Text] [Related]
37. The inhibition of the cage-leaving response--a model for studies of the serotonergic neurotransmission in the rat.
Rényi L; Archer T; Minor BG; Tandberg B; Fredriksson A; Ross SB
J Neural Transm; 1986; 65(3-4):193-210. PubMed ID: 3011984
[TBL] [Abstract][Full Text] [Related]
38. Further evidence that the serotonin receptor in the rat stomach fundus is not 5HT1A or 5HT1B.
Cohen ML; Wittenauer LA
Life Sci; 1986 Jan; 38(1):1-5. PubMed ID: 3941588
[TBL] [Abstract][Full Text] [Related]
39. A pharmacologic examination of receptors mediating serotonin-induced bronchoconstriction in the anesthetized guinea pig.
Buckner CK; Dea D; Liberati N; Krell RD
J Pharmacol Exp Ther; 1991 Apr; 257(1):26-34. PubMed ID: 2019990
[TBL] [Abstract][Full Text] [Related]
40. Serotonin receptor subtype mediation of the interoceptive discriminative stimuli induced by 5-methoxy-N,N-dimethyltryptamine.
Spencer DG; Glaser T; Traber J
Psychopharmacology (Berl); 1987; 93(2):158-66. PubMed ID: 3122248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
